Hub gene of disulfidptosis-related immune checkpoints in breast cancer

Y Wang, Y Deng, H Xie, S Cao - Medical Oncology, 2023 - Springer
Disulfidptosis and immune checkpoint genes play an important role in tumor treatment. But
there has been less research on the relationship between disulfidptosis and immune …

B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention

E Varghese, SM Samuel, A Brockmueller… - Cancer and Metastasis …, 2024 - Springer
Abstract B7-H3 (B7 homology 3 protein) is an important transmembrane immunoregulatory
protein expressed in immune cells, antigen-presenting cells, and tumor cells. Studies reveal …

A promising target for breast cancer: B7-H3

Y Jiang, J Liu, L Chen, Z Qian, Y Zhang - BMC cancer, 2024 - Springer
Breast cancer (BC) is the second-leading factor of mortality for women globally and is
brought on by a variety of genetic and environmental causes. The conventional treatments …

Anti-Cancer Immune Priming with Beta-Radioligand Therapy and Isoform-Selective Targeting of 4Ig-B7-H3

SE Glazer, MN Sutton, P Yang, F Pisaneschi… - bioRxiv, 2024 - biorxiv.org
Radioligand therapy (RLT), a re-emerging oncologic strategy using molecularly-targeted
therapeutic radioisotopes, clinically reduces tumor burden and enhances survival for select …